Skip to content

Medical emergency? What to do

Vioxx harmful even after patients stopped taking it

3-RXPublished December 15, 20103 min read

Key points

  • Merck's withdrawn painkiller Vioxx may have continued to cause blood clots and perhaps deaths even after patients dropped it, U.S. researchers said Monday.
  • The new findings, published in the Archives of Internal Medicine, are based on data made available by Merck during multibillion-dollar litigation against the company.
  • What happens after that is still an open question, said Dr.
  • Harlan Krumholz, also of Yale, said the study also stokes concerns about painkillers in the same class as Vioxx -- the so-called selective COX-2 inhibitors.

Merck's withdrawn painkiller Vioxx may have continued to cause blood clots and perhaps deaths even after patients dropped it, U.S. researchers said Monday.

The drug was recalled by Merck in 2004 after a colon-polyp prevention study showed it increased the risk of heart disease and death in users. But over the five years it was on the market, researchers estimate it caused nearly 40,000 deaths.

The new findings, published in the Archives of Internal Medicine, are based on data made available by Merck during multibillion-dollar litigation against the company.

They show patients taking Vioxx (also called rofecoxib) doubled their chances of having blood clots or dying in the first half-year after discontinuing treatment, confirming earlier results that hinted the effects might last up to one year.

What happens after that is still an open question, said Dr. Joseph Ross of the Yale School of Medicine in New Haven, who worked on the study.

"At this point, there isn't evidence to suggest that patients need to discuss with their physicians whether they are at increased risk after discontinuing Vioxx more than 6 years ago," he said in an e-mail to Reuters Health.

His co-author Dr. Harlan Krumholz, also of Yale, said the study also stokes concerns about painkillers in the same class as Vioxx -- the so-called selective COX-2 inhibitors.

When scientists first discovered these drugs, the hope was they would lower the risk of ulcers among chronic users of non-steroidal anti-inflammatory drugs, or NSAIDS, such as people with rheumatoid arthritis.

But most COX-2 inhibitors -- a subset of the NSAID category -- ran into safety issues a few years after their approval, and now only Pfizer's Celebrex (celecoxib) remains on the U.S. market. Other NSAIDs include low-dose naproxen, ibuprofen, ketoprofen and aspirin.

In the new study, the team looked at 617 patients who had stopped taking either Vioxx or a dummy pill following more than a year and a half of use.

After six months, on average, 22 patients on Vioxx reportedly developed blood clots and 23 died. Among those taking the placebo, the numbers were six and nine, respectively, at four months.

That translates into an overall rate of deaths or blood clots of 0.11 per year after a patient drops Vioxx -- twice as high as seen in the placebo group.

"It indicates a need for more research to understand better how these drugs confer risk," Krumholz said in an e-mail, "and whether we need to know whether people have ever taken these types of medications when we assess risk."

"For future drug evaluation and development we need to pay attention to effects that may manifest after the drug has been discontinued," he added. "To me, these results from the Vioxx studies about what happened to people after they stopped taking the drug may even be more important than the studies that showed risk when they were on the drug."

Both Krumholz and Ross have consulted for the plaintiffs in lawsuits against Merck. Their co-authors also report having received fees from several pharmaceutical companies.

Merck did not respond to a request for comment on the new findings.

Dr. John Baron of Dartmouth Medical School in Lebanon, New Hampshire, who oversaw the colon-polyp study for Merck, said most experts now believe the increased risks are a common trait among COX-2 inhibitors.

He said a new study testing all the drugs in the class is in the works.

"The most important analysis will be the combined analysis that will give more information regarding the individual drugs as well as presumed class estimates," he told Reuters Health.

SOURCE: Archives of Internal Medicine, online December 13, 2010.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug Abuse
Drug Abuse

Study raises caution on new painkillers

A new class of painkillers that block a receptor called TRPV1 may interfere with brain functions such as learning and memory, a new study suggests. The experiments with rat brain found that the TRPV1 receptor…

4 min read

Cancer

Cancer pill could affect women's fertility - report

Long-term use of the cancer pill Gleevec may produce fertility problems in women, Greek doctors reported on Wednesday. Chemotherapy and radiation have long been known to damage the fertility of patients, but little…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.